Neuphoria Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $23.2M |
| FY2023 | $6.6M | $28.6M | $12.1M |
| FY2024 | $10.2M | $27.6M | $12.6M |
| FY2025 | $9.6M | $28.6M | $14.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $23.2M |
| FY2023 | $6.6M | $28.6M | $12.1M |
| FY2024 | $10.2M | $27.6M | $12.6M |
| FY2025 | $9.6M | $28.6M | $14.2M |